SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is currently seeing a parabolic ascent to new all-time highs, fueled by intense bullish momentum. This surge is driven by tightening global supply, notably from impending Chinese export restrictions, coupled with escalating industrial demand for EV batteries, solar, and AI data centers. The community is actively discussing a potential "silver squeeze" and a significant re-rating of silver's value relative to gold, although some participants anticipate a near-term consolidation after its rapid rally.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is seeing significant attention following reports of high-grade silver drill results from its Vortex system, suggesting substantial resource expansion. This development, combined with a strong rally in broader silver prices, is fueling community discussions about the mine's immense potential and the possibility of a short squeeze. Investor Eric Sprott's continued share purchases are also contributing to a bullish sentiment, although some debate its current valuation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a recent FDA Type B meeting regarding its lead drug, Sonelokimab, with investors eagerly anticipating clarity on its path to BLA submission for Hidradenitis Suppurativa. The community is highly optimistic about Sonelokimab's "Best in Class" potential and widely discussing an imminent acquisition by Merck, with many interpreting recent insider share conversions as preparatory for a potential buyout in the $75-$90 range. Despite perceived institutional efforts to suppress the stock price, many investors remain steadfast, highlighting the drug's strong scientific data and significant market opportunity.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold pushes to new all-time highs, fueled by escalating geopolitical concerns and expectations of continued central bank liquidity. The community is actively debating if this surge is a macro warning sign amid global monetary instability, frequently contrasting its robust performance with struggling cryptocurrencies and noting significant central bank accumulation.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is drawing significant attention as its merger target, Infleqtion, garners excitement for its commercial-ready quantum sensing and timing solutions, bolstered by new partnerships in defense and tech. The investment community is actively discussing Infleqtion's perceived undervaluation compared to its quantum peers and its potential as a leader with tangible applications, especially as the anticipated merger approaches.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is a top trending stock after securing FDA approval for its oral Wegovy, establishing it as the first GLP-1 weight-loss pill. This significant development has ignited widespread community discussion about the immense potential for market expansion due to the convenience of a pill over injections and its strategic positioning in the evolving obesity treatment landscape against rivals like Eli Lilly. Many anticipate this catalyst could drive a substantial re-evaluation of the company's long-term value.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is currently trending due to a series of strategic partnerships and teaming agreements focusing on its thin-film solar technology for advanced space, defense, and drone applications. The community is actively debating its potential for a significant short squeeze, driven by an ultra-low float and speculative excitement around future contracts in the expanding space sector. However, many investors express caution, referencing the company's historical pattern of dilution and previous price volatility.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is currently a trending topic, largely driven by the announcement of its upcoming inclusion in the S&P MidCap 400, which has sparked widespread optimism among investors. The community is keenly focused on the company's strong positioning in the rapidly evolving "Agentic AI" sector, viewing it as a major catalyst for future growth despite some recent discussions around profit-taking and market fluctuations.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings ($RGC) is capturing attention amid community speculation driven by its low float, high insider ownership, and reported share accumulation by its CEO. Many anticipate a significant short squeeze, frequently comparing its current setup to past instances of extreme volatility and the stock's own historical rallies, fueled by discussions around high cost to borrow.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Trust - ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is trending as the community anticipates a major surge in silver prices, driven by its perceived undervaluation relative to gold and increasing industrial demand from sectors like AI and EVs. Macroeconomic catalysts, including global uncertainties and anticipated rate adjustments, are intensifying conviction among traders that silver is on the cusp of a historic breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CTO Realty Growth, Inc. (NYSE:CTO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of CTO Realty Growth, Inc. (NYSE:CTO - Get Free Report) have received an average rating of "Moderate Buy" from the five ratings firms that are currently covering the firm, MarketBeat.com...

CTO Realty Growth (NYSE:CTO) Rating Lowered to Hold at Zacks Research

Zacks Research lowered CTO Realty Growth from a "strong-buy" rating to a "hold" rating in a report on Tuesday...

Russell Investments Group Ltd. Sells 75,632 Shares of CTO Realty Growth, Inc. $CTO

Russell Investments Group Ltd. decreased its holdings in CTO Realty Growth, Inc. (NYSE:CTO - Free Report) by 14.1% in the second quarter, according to its most recent 13F filing with the SEC. The...

CTO Realty Growth, Inc. $CTO Stake Trimmed by LSV Asset Management

LSV Asset Management cut its position in shares of CTO Realty Growth, Inc. (NYSE:CTO - Free Report) by 4.8% in the second quarter, according to its most recent disclosure with the Securities and...

CTO Realty Growth, Inc. (NYSE:CTO) Plans Quarterly Dividend of $0.38

CTO Realty Growth, Inc. (NYSE:CTO) declared a quarterly dividend on Tuesday, November 18th. Shareholders of record on Thursday, December 11th will be paid a dividend of 0.38 per share on Wednesday...

CTO Realty Growth, Inc. $CTO Shares Bought by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC raised its position in CTO Realty Growth, Inc. (NYSE:CTO - Free Report) by 72.9% in the second quarter, according to its most recent Form 13F filing with the SEC...

Implied Volatility Surging for CTO Realty Growth Stock Options

Investors need to pay close attention to CTO stock based on the movements in the options market lately. 

CTO Realty (CTO) Beats Q3 FFO and Revenue Estimates

CTO Realty (CTO) delivered FFO and revenue surprises of +2.04% and +0.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Kilroy Realty (KRC) Q3 FFO and Revenues Surpass Estimates

Kilroy Realty (KRC) delivered FFO and revenue surprises of +9.00% and +2.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Can CTO Realty (CTO) Climb 28.19% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 28.2% upside potential for CTO Realty (CTO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

CTO Realty Growth, Inc. operates as a real estate company. It owns and manages commercial real estate properties. The company was founded in 1910 and is headquartered in Winter Park, FL.

Current Price	$17.76
Prev Close	$17.72
Open	$17.79
Dividend Yield	7.71%
50-Day Moving Average	$17.21
Beta	0.54
Avg. Volume	235,980.16
PE Ratio	-13.75

52-Week High	$20.88
52-Week Low	$15.07
Market Capitalization	$573.64M
EPS (Annual)	-$0.3462
Price to Book	1.04
Revenue Per Employee	$3.37M
Enterprise Value/EBITDA	N/A

CTO
CTO Realty Growth Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTO News

CTOCTO Realty Growth Inc